Regenerative therapies company Cytomedix has received clearance from the Therapeutic Goods Administration (TGA) to commercialize its Angel cPRP system in Australia. The approval allows the company to use the system in the clinic or ...
Tags: Cytomedix, TGA, Angel cPRP system
Cytomedix has featured its AutoloGel system at the Native American Wound Care Conference and Diabetic Limb Salvage Conference. The FDA-cleared AutoloGel system is designed for the production of autologous platelet rich plasma (PRP) for ...
Tags: Cytomedix, AutoloGel system, PRP, wound management
The US Food and Drug Administration (FDA) has granted 510(K) approval to Cytomedix to use its Angel Concentrated Platelet Rich Plasma (cPRP) system to process a small sample of blood or a mixture of blood and bone marrow aspirate. ...